Diabetes and metabolism Archives - Page 2 of 5 - Healthed

Diabetes and metabolism

Diabetes and metabolism, Drugs and devices, Endocrinology

Prof Sunil Badve

Videos

Finerenone for chronic kidney disease in type 2 diabetes

In this Product Explainer, Nephrologist Prof Sunil Badve explains the role of finerenone to delay progressive decline of kidney function in adults with chronic kidney disease (CKD) associated with Type 2 diabetes with albuminuria.

Expert/s: Prof Sunil Badve

Diabetes and metabolism

Dr Duane Mellor

Clinical Articles

Is diabetes remission really as hard to achieve as a new study suggests?

We have known about cases of type 2 diabetes going into remission, or glucose levels going back to normal, since the 1960s. But how likely is it that this treatment will work outside of the carefully controlled environment of a clinical trial?

Expert/s: Dr Duane Mellor, Craig Russell, Clinical A/Prof Srikanth Bellary

Diabetes and metabolism

Clinical Articles

Preventing DKA in kids – tips to make a timely type 1 diabetes diagnosis

Cases of diabetic ketoacidosis (DKA) in children are on the rise in Australia, sometimes with tragic consequences, says paediatric endocrinologist A/Prof Gary Leong—and empirical evidence supports this observation.

Expert/s: Sophia Auld

Diabetes and metabolism

Podcasts

Weight loss for better type 2 diabetes outcomes – Your questions answered

The questions answered in this podcast are listed. They were compiled by GPs and health professionals around Australia regarding weight loss for better type 2 diabetes outcomes.

Expert/s: Dr Gary Deed

Diabetes and metabolism, Diet and nutrition

Manuela Callari

Clinical Articles

Obesity drugs – What’s around the corner

Ozempic has only been approved and funded for lowering blood glucose levels in people with T2D. Wegovy, the higher dose version of semaglutide, has been approved specifically for weight loss, learn more...

Expert/s: Manuela Callari

Diabetes and metabolism

Clinical Articles

Ozempic drought continues

Worldwide shortages cause to TGA put the brakes on prescribing

Expert/s: Healthed

Diabetes and metabolism

Clinical Articles

Body mass index: why practitioners are relying on it less when looking at a patient’s health

ody mass index has long been used by doctors as the standard method for measuring health – and often still is.

Expert/s: Healthed

Diabetes and metabolism

Clinical Articles

WHO’s recommendation against the use of artificial sweeteners for weight loss leaves many questions unanswered

Do low-calorie sweeteners help with weight management? And are they safe for long-term use?

Expert/s: Lindsey Schier, Dr Scott Kanoski

Diabetes and metabolism

Podcasts

Bariatric surgery options for obesity

Obesity is the disease of our generation- managing obesity and the complications of obesity to suit each individual patient's requirements and needs.

Expert/s: Dr Michael Hii

Diabetes and metabolism

Dr Sarah Tedjasukmana

Clinical Articles

GLP-1s for T2D – the earlier the better?

Experts say GLP-1 RAs should be prescribed more often and earlier, citing compelling benefits for type 2 diabetes—but the PBAC has other ideas.

Expert/s: Dr Sarah Tedjasukmana

Diabetes and metabolism

Lynnette Hoffman

Clinical Articles

Obesity & metabolic syndrome in kids is a growing problem

It’s no anomaly for Associate Professor Gary Leong to see patients as young as 10 who weigh 100 kilograms.

Expert/s: Lynnette Hoffman

Diabetes and metabolism, Endocrinology, Ophthalmology

Prof Richard O'Brien

Videos

Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes

In this Product Explainer, Endocrinologist Prof Richard O'Brien explains the role of Fenofibrate in reducing the progression of diabetic retinopathy in patients with type 2 diabetes (5 mins).

Expert/s: Prof Richard O'Brien

Education by clinicians, for clinicians

Get the app

Site

Company

Connect

Legal